NASDAQ:PHAT | Insider Transactions — Page 3 | Phathom Pharmaceuticals, Inc.

PHAT Insider Transactions — Page 3

212 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 201–212; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Nabulsi AzmiChief Operating Officer2020-01-05Sale1,854.0$33.77
Nabulsi AzmiChief Operating Officer2020-01-04Sale100.0$34.57
Nabulsi AzmiChief Operating Officer2020-01-04Sale7,614.0$33.93
Nabulsi AzmiChief Operating Officer2020-01-04Sale4,932.0$33.02
COLA MICHAEL FDirector2019-10-29Purchase9,798.0$19.0
Edwards Jonathan S.Director2019-10-29Purchase24,426.0$19.0
Edwards Jonathan S.Director2019-10-29Purchase1,028,205.0$19.0
Topper James NDirector,TenPercentOwner2019-10-29Purchase1,052,631.0$19.0
Heron Patrick JTenPercentOwner2019-10-29Purchase1,052,631.0$19.0
Frazier Life Sciences IX, L.P.TenPercentOwner2019-10-29Purchase1,052,631.0$19.0
FHMLS IX, L.P.TenPercentOwner2019-10-29Purchase1,052,631.0$19.0
FHMLS IX, L.L.C.TenPercentOwner2019-10-29Purchase1,052,631.0$19.0